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• Pooled 1000 patient endocervical swab samples into groups of 10 prior to 
analysis to:
• Streamline time required for analysis
• Reduce the amount of resources required
• Extracted and screened viral RNA for a portion of the HIV-1 gag gene 
via reverse transcription polymerase chain reaction and DNA gel electrophoresis
• Communicated with Arts laboratory on a weekly basis to discuss progress and 
troubleshoot project issues
• To date, of the 1000 screened endocervical swabs, we identified 14 pools as HIV-positive
Jason Knapp (MSc Microbiology & Immunology)
Reshele Perera & Felicia Krausert (MMASc Global Health Systems) May – August 2017
• We conducted our research at the Joint Clinical Research Centre
(JCRC), located in Lubowa, Uganda
• It is currently believed that once a HIV infection is established at the
mucosal level, an ensuing systemic infection is certain to follow
• The transmission rate of HIV through receptive vaginal intercourse
is estimated to be 0.08% (roughly every 1 in 1000 sexual encounters
with an HIV-positive person resulting in infection)
• In some cases, female commercial sex workers have cytokine
patterns in their genital tract that are associated with protection
against HIV-1 infection
• We predict that HIV infection in the female genital tract may
occur in the absence of systemic infection in some individuals
1. To investigate whether HIV infection may occur in the female genital tract in the absence of systemic infection in some
individuals
2. Screen endocervical swab samples isolated from HIV-negative Ugandan and Zimbabwean women for the presence of HIV
• Ordering issues between Western
University and Kenyan company
providing supplies
• Ordered supplies took very long to
arrive. For example, it was quicker
to order some supplies in Canada
and ship them to Uganda than to
order them in Africa
• Difficulty in upholding weekly video
calls with lab in different time zone
• Four month time restraint in
Uganda combined with delay of
supplies reduced our available
working time in half
• Sharing of limited laboratory
resources often restricted the
amount of work that could be
completed
• Order project supplies well in
advance of arrival at host
organization. Alternatively, have
host organization order supplies on
our behalf to avoid shipment delays
• Maintain weekly video call
meetings with project supervisor in
Canada. This will ensure that any
issues that arise are dealt with as
soon as possible
• Allocate additional time to the study
period in case of unforeseen issues
such as shipment delays
• Invest in the Joint Clinical
Research Centre to purchase more
laboratory equipment
• Our preliminary results suggest
that HIV infection contained in the
female genital tract in the
absence of systemic HIV infection
may occur
• These results provide the
confidence required to pursue this
project on a larger scale and
increase funding for its
continuation
• This novel discovery may lead to
increased knowledge on HIV
transmission and impact scientific
advancement in regards to the
HIV epidemic
• Research conducted in the summer
has elucidated that both time
management and organizational
skills will be absolutely essential to
the success of the project
• Conducting HIV research in
Uganda versus Canada was an
incredible experience that has
irrevocably shaped our views of
HIV. Working in a country that has
been devastated by HIV has
strengthened our drive to battle the
advancing epidemic
• Witnessing a ‘wicked problem’ first
hand has instilled a newfound
appreciation for the importance of
understanding not just scientific
knowledge of HIV, but also the
social, political, and environmental
factors surrounding HIV in order to
effectively combat the epidemic to
the best of our ability
• Screen roughly 2000 more endocervical
samples from HIV-negative women for the
presence of HIV
• Sequence virus identified from samples via
Sanger sequencing and analyze for
common patterns and mutations
• Perform an analysis of the cytokines
present in the endocervical swabs and
compare with that of HIV-negative and
systemically HIV-positive women
